Literature DB >> 11274028

ELISA methodology for detection of modified osteoprotegerin in clinical studies.

D Chen1, N A Sarikaya, H Gunn, S W Martin, J D Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274028

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

Review 1.  Evolving role of bone biomarkers in castration-resistant prostate cancer.

Authors:  Janet E Brown; Sheryl Sim
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

Review 2.  The pharmacokinetics and pharmacodynamics of denosumab in patients with advanced solid tumours and bone metastases: a systematic review.

Authors:  Winnie Sohn; Mary Ann Simiens; Kelly Jaeger; Shauna Hutton; Graham Jang
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

3.  Relationship of sympathetic activity to bone microstructure, turnover, and plasma osteopontin levels in women.

Authors:  Joshua N Farr; Nisha Charkoudian; Jill N Barnes; David G Monroe; Louise K McCready; Elizabeth J Atkinson; Shreyasee Amin; L Joseph Melton; Michael J Joyner; Sundeep Khosla
Journal:  J Clin Endocrinol Metab       Date:  2012-09-04       Impact factor: 5.958

4.  Enzyme-catalyzed Ag Growth on Au Nanoparticle-assembled Structure for Highly Sensitive Colorimetric Immunoassay.

Authors:  Xuan-Hung Pham; Eunil Hahm; Tae Han Kim; Hyung-Mo Kim; Sang Hun Lee; Yoon-Sik Lee; Dae Hong Jeong; Bong-Hyun Jun
Journal:  Sci Rep       Date:  2018-04-19       Impact factor: 4.379

Review 5.  Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.

Authors:  Theodoros Kelesidis; Judith S Currier; Otto O Yang; Todd T Brown
Journal:  AIDS Rev       Date:  2014 Jul-Sep       Impact factor: 2.381

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.